Dr Zaius wrote:
Attention MDs and Scientists:
It has come to my attention that calling the FDA at (888) 463-6332 is an effective way to lobby for leronlimab to receive more attention and consideration within the FDA.
The caveat is that those who call should be well versed in the science and MOA of leronlimab in COVID-19. The FDA will listen to credible parties who express support and provide information about the science of leronlimab.
Probably not a good idea to call as an 'investor' or with the intent to pressure the Agency.
Read More: https://investorshangout.com/post/newpost/605...z6pfSCZo4H
Very good guidance that only MDs and scientists should call. Unfortunately, someone posted this on Yahoo about 4 hours ago :
Please everyone do this. This is copied from Reddit.
Hey team, it's been suggested that the FDA prioritizes drugs that get a lot of attention. If every one of us called in and left a message about leronlimab and CytoDyn they would certainly take notice. We know they already know about the drug but why not apply a little pressure. It only takes 2 minutes and can't hurt.
Here is the process:
Dial 888-463-6332
Press 3 (to speak to a rep, but don't worry you don't talk to anyone)
Press 1 (for biologics)
Press 1 (for consumers)
You'll then be asked to leave a message. I recommend stating something like this:
I'm calling to ask about a covid drug called Leronlimab (then I spelled it for them) from a company called Cytodyn. It just finished a very successful phase 3 study and I'm curious when it will be available. Its safety profile is incredible and the way it works, its mechanism of action, should work on any strain of covid. This drug seems like a huge benefit. It may even prevent long-hauler syndrome... I wanted to be sure this drug is on your radar!
Please consider taking 2 minutes out of your day to do this now! Share this with other interested parties.
This is what Dr Z warned against (unless the last "1" for consumers goes to a different group than whatever extension doctors call in to). That post already has 44 thumbs up. A few posters replied that only doctors should do this but those replies are getting minimal thumbs up.
Attention MDs and Scientists:
It has come to my attention that calling the FDA at (888) 463-6332 is an effective way to lobby for leronlimab to receive more attention and consideration within the FDA.
The caveat is that those who call should be well versed in the science and MOA of leronlimab in COVID-19. The FDA will listen to credible parties who express support and provide information about the science of leronlimab.
Probably not a good idea to call as an 'investor' or with the intent to pressure the Agency.
Read More: https://investorshangout.com/post/newpost/605...z6pfSCZo4H
Very good guidance that only MDs and scientists should call. Unfortunately, someone posted this on Yahoo about 4 hours ago :
Please everyone do this. This is copied from Reddit.
Hey team, it's been suggested that the FDA prioritizes drugs that get a lot of attention. If every one of us called in and left a message about leronlimab and CytoDyn they would certainly take notice. We know they already know about the drug but why not apply a little pressure. It only takes 2 minutes and can't hurt.
Here is the process:
Dial 888-463-6332
Press 3 (to speak to a rep, but don't worry you don't talk to anyone)
Press 1 (for biologics)
Press 1 (for consumers)
You'll then be asked to leave a message. I recommend stating something like this:
I'm calling to ask about a covid drug called Leronlimab (then I spelled it for them) from a company called Cytodyn. It just finished a very successful phase 3 study and I'm curious when it will be available. Its safety profile is incredible and the way it works, its mechanism of action, should work on any strain of covid. This drug seems like a huge benefit. It may even prevent long-hauler syndrome... I wanted to be sure this drug is on your radar!
Please consider taking 2 minutes out of your day to do this now! Share this with other interested parties.
This is what Dr Z warned against (unless the last "1" for consumers goes to a different group than whatever extension doctors call in to). That post already has 44 thumbs up. A few posters replied that only doctors should do this but those replies are getting minimal thumbs up.
